Incubation of ex vivo cultured mature B cells in the presence of nitric oxide or nitric oxide-donor substances delays programmed cell death as determined by the appearance of DNA laddering in agarose gel electrophoresis or by flowcytometry analysis of DNA. Nitric oxide also rescues B cells from antigen-induced apoptosis but fails to provide a costimulatory signal that converts the signal elicited by the antigen into a proliferative response. The protective effects of nitric oxide against programmed cell death can be reproduced by treatment of the cells with permeant analogues of cyclic GMP. Regarding the mechanisms by which nitric oxide prevents apoptosis in B cells, we have observed that nitric oxide release prevents the drop in the expression of the protooncogene bcl-2, both at the mRNA and protein levels, suggesting the existence of an unknown pathway that links nitric oxide signaling with Bcl-2 expression. (J. Clin.
Introduction
Programmed cell death (PCD)' is a process through which individual cells are deleted in the course of development or cell turnover in many tissues ( 1, 2) . In the immune system negative selection of the B and T cell lineages is mediated by apoptosis (3) (4) (5) . Current perspectives implicate growth factors, a wide array of cytokines and hormones, as well as the level of expression of "antiapoptotic" genes, such as bcl-2, bcl-x, or bax, as critical factors controlling PCD (6) (7) (8) .
Isolated mature splenic B cells, in contrast to isolated mature T cells, rapidly undergo apoptosis in the absence of activation by specific antigens or polyclonal mitogens (3) (4) (5) . However, in immature B cells, such as the lymphoma WEHI-231 cell line, signaling through the IgM membrane receptor results in cell growth arrest and in the initiation of a series of events characteristic of PCD, therefore suggesting an important role of PCD in 1. Abbreviations used in this paper: cGMP, cyclic GMP; PCD, programmed cell death; PDBu, phorbol 12,13-dibutyrate; SIN-1, 3-morpholinosydnonimine; sMHC-I, soluble MHC-I. the deletion of autoreactive B cells (9) . The same holds true for B cell precursors derived from fetal liver or bone marrow that require the supply of exogenous IL-3 or IL-7 for in vitro growth, and initiate a precocious PCD after depletion of these factors (10). The levels of Bcl-2, a protein encoded by a gene isolated from the break point of translocations between chromosomes 14 and 18 that is highly expressed in various B cell lymphomas ( 11) , have been shown to be important for prevention of apoptosis (7, 12, 13) . Indeed, overexpression of bcl-2 in B cells has a protective function against apoptosis (14) (15) (16) . However, in the case of T cells from mice carrying a bcl-2 transgene, clonal deletion persists despite the expression of high levels of bcl-2, suggesting the existence of alternative pathways controlling the switch from proliferation to apoptosis (17, 18) .
Since little is known about the nature of the intracellular pathways involved in the control of bcl-2 levels and finally in prevention of PCD, we examined the role of nitric oxide as a possible candidate for PCD modulation in ex vivo cultured B cells. A role of nitric oxide has been proposed in physiopathological situations involving activation of the immune system, such as in the graft versus host disease (19) or deletion of activated macrophages (20) . Nitric oxide is synthesized by nitric oxide synthase, from which at least three different genes have been identified (21, 22) . The mechanism of action of nitric oxide involves covalent modification of proteins (ADP ribosylation and S-nitrosylation), as well as the activation of a soluble guanylate cyclase, cyclic GMP (cGMP), as messenger (21) (22) (23) . Moreover, it has been proposed that nitric oxide may also influence gene expression as reported for the calcium-mediated transcription of early genes in neural cells, opening a new view concerning the biological effects of this messenger (24) .
Here we report that the presence of a low but sustained nitric oxide release prevents apoptosis. This prevention appears to be mediated by an increase in intracellular cGMP and leads to the maintenance of significant levels of bcl-2 transcription. These results offer new clues for the understanding of PCD and describe an alternative pathway to maintaining B cell survival as well as to linking nitric oxide release to the maintenance of Bcl-2 expression. and mechanically disrupted (1-mm metal mesh). The cell suspension was kept in RPMI 1640 medium and filtered through a 10-pm nylon mesh. Nonlymphoid cells were removed by centrifugation over a FicollHypaque (Pharmacia, Uppsala, Sweden) discontinuous gradient. After three washes with RPMI 1640 the cells were resuspended in this medium containing 10% of batch-tested nonstimulatory FCS, 2 mM glutamine, 50 .tg/ml antibiotics, and 50 ,uM ,-mercaptoethanol. B cells were prepared after treatment with anti-Thy-1 antibody plus complement (26) . To remove adherent cells, the cell suspension was incubated for 30 min in plastic tissue culture dishes in the same medium. The purity of the B cell population was assessed by immunofluorescence on a FACScan' cytofluorometer (Becton Dickinson and Co., Cockeysville, MD) and resulted in the expression of > 95% Ig' and < 1% of Thy-1.2+ cells.
The macrophage contamination in these preparations ranged from 1 to 3% as determined by CD1 lb staining. When FACSO (Becton Dickinson and Co.) analysis was used, electronic gating of the lymphocyte population was performed and the macrophage contamination was reduced to < 0.1%. Cell viability was estimated according to the propidium iodideexclusion criteria, and was > 95%. B lymphocytes were maintained at 1 x 106 cells/ml in the above described RPMI 1640 medium.
NO sources. Nitric oxide was intracellularly generated using NOdonors (27) Bcl-2 detection. The amount of Bcl-2 protein was determined using a flow cytometry-based method (7). B cells (5 x 105) were washed twice with PBS and stained with FITC-labeled anti-B220 mAb. After washing twice with PBS, the cells were fixed with PBS containing 4% paraformaldehyde at 20°C for 10 min. After two washes in PBS, the cells were permeabilized with 50 ,ug/ml of digitonin in PBS for S min, the process was stopped by dilution in 0.1 vol of FCS, and the cells were kept at 4°C. Aliquots (2 x 105 cells) were extensively washed and incubated for 1 h in PBS with a hamster mAb specific for murine Bcl-2, or a control hamster mAb. The cells were washed and incubated with F(ab')2 biotinylated rabbit anti-hamster IgG for 30 min at 4°C and after staining were analyzed in a FACScans flow cytometer (Becton Dickinson and Co.). More than 90% of the cells were permeabilized, as assessed after the staining with propidium iodide. Alternatively, the total levels of Bcl-2 were determined by Western blot analysis using a goat anti-hamster IgG-POD as secondary antibody and revealing the blot following the enhanced chemiluminescence protocol (Amersham).
Determination of cGMP. cGMP was measured in cultures supplemented with 0.5 mM isobutyl-l-methylxanthine to favor the accumulation of this messenger. B cells were stimulated for 2 h, and, after washing with PBS, the cell pellets were resuspended in 0.2 ml of an ice-cold mixture of ethanol:water (2:1, vol:vol). After thorough mixing and centrifugation in an Eppendorf centrifuge (Brinkmann Instruments, Inc., Westbury, NY), samples were speed vacuum-dried and cGMP was measured using a specific binding kit, following the recommendation of the supplier (Amersham).
[3H]Thymidine incorporation. Proliferation was determined by culturing 105 cells per well in 96-well plates. 1 
Results
Nitric oxide release delays PCD in B cells. Ex vivo isolated purified splenic B cells, when kept unstimulated, suffered a progressive time-dependent degradation of DNA that was followed by the appearance of a DNA fragmentation pattern observed by agarose gel electrophoresis ( Fig. 1 A, -lanes) . However, when cells were incubated in the presence of substances that produced a continuous release of nitric oxide (27) , such as 3-morpholinosydnonimine (SIN-1), a clear delay in the appearance of the apoptotic ladder pattern was observed ( Fig. 1  A, + lanes) . of cells displaying degradation of DNA was followed by specific changes in the DNA fluorescence when the cells were stained with propidium iodide and analyzed by flow cytometry. As shown in Fig. 1 B, after 6 h of culture, up to 77% of the B cells from the untreated population displayed a typical pattern of apoptosis (R3 plus R4) frequency that decreased to 19% in the presence of SIN-1. To further ensure that the apoptotic B cell population identified by flow cytometry effectively corresponded to cells with internucleosomal DNA fragmentation, the populations discriminated in Fig. 1 B were separated by sorting and analyzed by agarose gel electrophoresis (Fig. 1 C) . The subpopulation selected in gates R3 + R4 is the only one undergoing DNA fragmentation when compared to the R1 population. This protective effect of SIN-1 was also achieved by isosorbide dinitrate, another NO-donor, as well as by repetitive priming of the incubation with a fresh solution of nitric oxide in RPMI 1640-Hepes medium depleted of oxygen (the initial concentration of nitric oxide in this solution was 1 1tM). The endogenous NO production in the culture was negligible and below the nM range after 6 h of culture. In agreement with the absence of endogenous NO release, the presence of 0.5 mM nitromethylarginine (a nitric oxide synthase inhibitor) in the incubation medium did not alter the apoptotic profile of B cells (not shown). The protective effect of SIN-1 against PCD was dose dependent, and the optimal concentration was 1 buM (Table I) . As a control, rescue of B cells from PCD by stimulation with either LPS or surface immunoglobulin mAb plus IL-4 decreased the percentage of cells in the R3 + R4 panels (Table I) .
Nitric oxide prevents sMHC-I-induced apoptosis in B cells. We have recently described a system where B cells expressing a surface immunoglobulin specific for the H-2kk haplotype of MHC-I, when stimulated with MHC-I alloantigen H-2Kk, initiate a rapid signaling process that results in apoptosis, an effect that is prevented by some costimulatory signals, among them those involving protein kinase C activation (26) . In the present study we tested the role of NO-donors in this system to validate its protective role against PCD as a positive costimulatory signal in a model of antigen-induced PCD. As shown in Fig. 2 (Fig. 2 B) . Accordingly, to ensure that cGMP was involved in the mechanism of action of nitric oxide in B lymphocytes, experiments were undertaken in which cGMP was measured after stimulation of B cells. As Fig. 3 shows, incubation of B lymphocytes for 2 h in the presence of SIN-I produced a 7.2-fold increase in cGMP. The same result was obtained with sodium nitroprusside, a caged NO-releasing compound. As a control, a fresh solution of nitric oxide (1 ktM final concentration) was added to determine the maximal activation of guanylate cyclase in these cells.
Having shown that nitric oxide release in B cells involves 39 42 SIN-I (1 AM) 20 19 SIN-1 (10 jM) 19 19 SIN-1 (100 AM) 28 31 Isosorbide dinitrate (1 AM) 24 26 Nitric oxide* (1 AM) 18 25 LPS (25 Ag/ml) 17 19 sIg-mAb (5 mice carrying a jJK transgene were purified as previously described (see Fig. 1 ). The cells were incubated for 2 h with 1 pM SIN-1 (A), or 100 ng/ml of purified sMHC-I, 10 nM dibutyryl-cGMP, and 2 ng/ ml PDBu (B). The figure shows a representative experiment out of three in which the same cell preparation has been incubated with the indicated ligands.
the activation of guanylate cyclase, we further determined that cGMP mediated the protective effect of nitric oxide against PCD using flow cytometry. As Fig. 4 shows, incubation of the cells for 4 whether this situation also applies to B cells incubated with nitric oxide-releasing compounds, we determined the levels of bcl-2 mRNA and protein in B cells derived from pK transgenic mice incubated with sMHC-I in the presence of several ligands known to modulate the response to sMHC-I alloantigen. As Fig.  5 shows, exposure of B cells from pK transgenic mice to sMHC-I elicited a drastic drop in the bcl-2 RNA level, an effect that was partially antagonized by SIN-1 and PDBu but not by the inactive phorbol ester a-phorboldidecanoate. Indeed, in the presence of SIN-I (or PDBu), the bcl-2 RNA levels were at least three-to fourfold higher than those from unstimulated cells, reinforcing the view that nitric oxide release was sufficient to maintain the bcl-2 RNA levels. Moreover, when the Bcl-2 protein content was measured in situ in permeabilized B220+ cells using flow cell cytometry, a clear protective effect of SIN-1 was observed over the sMHC-I-induced drop in Bcl-2 ( Fig.  6 A) . Whereas the mean of the fluorescence distribution corresponding to Bc1-2 content decreased from 15 to 7 upon stimulation with sMHC-I, in the presence of SIN-1 the corresponding value was 12. Finally, the total amount of Bcl-2 was also measured by Western blot analysis, and, in agreement with data decribed above, the levels of Bcl-2 were enhanced after addition of SIN-I or a permeant cGMP analogue - (Fig. 6 B) . Time (hours)
Discussion
Cells were collected by centrifugation and processed as described for Fig. 1 B. Quantitative analysis of the apoptotic population was obtained by flow cytometry determining the percentage of cells in the R3 + R4 panels.
gen recognition, and specific cellular interactions; through all of these, the deletion or functional anergy of the precursor population occurs (32) (33) . Therefore, the control of the apoptotic process plays a selective role in the course of B cell maturation (32) (33) (34) .
The identification of the mechanisms involved in B cell survival through the different stages of proliferation and differentiation of the precursors is of interest for the understanding of B cell biology. For this reason, attention has been devoted to the identification of signaling pathways involved in these processes. The protective effect exerted through CD40 signaling in the blockage of the apoptosis in B cells induced after antigen receptor cross-linking is a good example (35) . CD40 in humans is expressed in both pre-B cells and mature B cells, and activation through this molecule prevents apoptosis not only in circulating B cells but also in immature B cell lines such as WEHI-231 cells (34, 35) . CD40 is closely related to the TNF-a receptor, whereas its natural ligand (CD40L) is structurally related to the family of TNF-a molecules. CD40L is expressed in the cell surface of activated T cells but not in resting T cells, therefore providing costimulatory signals in the process of B cell-T cell interaction (34, 35) . TNF is an inducer of nitric oxide release in different cell lines, among which are those of lymphoid origin (36, 37) . We thus considered the possibility that nitric oxide was one of these early molecules (second messengers) that participated in the control of PCD. Nitric oxide is a gaseous molecule released by different cells in .d 18a 12 3 4 5 endotoxins (21, (36) (37) (38) . Moreover, due to its chemical nature, nitric oxide may easily cross the cell membrane, acting both as an intra-and intercellular messenger, and for this reason it may play a role both in the germinal centers and in the process of recognition of circulating B cells by activated T cells.
The protective role of nitric oxide against PCD in B cells contrasts with the NO-dependent induction of apoptosis observed in other cell types such as macrophages (20) , which suggests the existence of cell-specific pathways in the response to nitric oxide. This opposite response to nitric oxide in B cells and macrophages is not unique since neuroprotective and neurodestructive effects of nitric oxide have been reported in neurons; this complex behavior has been explained on the basis of the different redox states of nitric oxide once released in the cytoplasm of the cell (39, 40) . Moreover, it is also possible that the involvement of other signaling molecules can influence the regulation of the expression of the inducible form of nitric oxide synthase as reported for the complex dual stimulation of macrophages with traces of LPS and IFN-y (41).
Regarding bcl-2, recent reports propose that the expression of this protoocogene has a protective role against oxidative stress, involving in neural tissues an increase in the intracellular concentration of glutathione (40) . In agreement with these reports, overexpression of bcl-2 in neural cell lines prevents PCD by decreasing the generation of reactive oxygen species (40), a situation that does not apply for B cells (42) . Our finding that nitric oxide maintains the bcl-2 levels both in unstimulated and sMHC-I-activated mature B cells offers a possible explanation for the antiapoptotic effect of nitric oxide in this particular system. Moreover, because Bcl-2 is a long-lived protein under normal conditions, the fall in Bcl-2 content after sMHC-I stimulation indicates that an active Bcl-2 degradation occurs under these conditions, and it suggests the existence of multiple pathways in the control of Bcl-2 degradation. This decrease in Bcl-2 content in cells displaying DNA degradation has been confirmed both by an in situ flow cytometry assay in permeabilized cells and after quantification of the total Bcl-2 content by Western blot analysis.
Expression of bcl-2 has been shown to be highly regulated along development of B lymphocytes. For instance, susceptibility to dexamethasone-induced PCD depends on the stage of B cell maturation and correlates well with the amount of bcl-2 expressed by individual cells (7) . The mechanism by which nitric oxide prevents the drop in bcl-2 mRNA levels is yet V ',.J unknown, but a few cases in which gene expression is modulated by nitric oxide as occurs in the amplification by nitric oxide of the calcium-dependent transcription of early genes in neuronal cells have been described (24) . The complex regulation of apoptosis and cell survival involves particular combinations of signals leading to pathways that are not always identified. Therefore, it is conceivable that PCD-inhibitory compounds can be used to counteract the increased apoptotic decay of lymphocytes, for instance, triggering after viral infection (43) . Moreover, these compounds may exert immunostimulatory effects by impeding the deletion and/or increasing the longevity of stimulated lymphocytes. The results here presented describe a new, useful pathway to prevent apoptosis of B cells, and may provide new insights into the link between the interactions at the membrane surface levels and the distal events that control B cell apoptosis or progression through the division cell cycle and terminal differentiation of B cells (44) .
